SecBot SecBot
8-K ·Filed May 14, 2026

SBCWW

SBC Medical Group Holdings Inc
BEARISH
Impact 6/10
Horizondays Processed5mo ago SEC0001193125-26-222720
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The 47% earnings decline and 900 bps EBITDA margin compression signal deteriorating profitability despite a modest revenue beat. With a $23M market cap, the stock is highly sensitive to earnings trajectory — watch for any guidance updates on the conference call and monitor whether the structural franchise fee headwind is truly behind the company as management claims.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
SBCWW ▲ +4.21% at T+60d
SHORT call ✗ call lost -4.21% · α vs SPY -0.62% · entry $0.2496 → $0.2601
Entry = T+0 close
May 14, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.23%
$0.2496
settled 6mo ago
T+5d
0.00%
call 0.00% · α -0.72%
$0.2496
settled 5mo ago
T+20d
-0.01%
call +0.01% · α -0.85%
$0.2496
settled 5mo ago
T+60d
+4.21%
call -4.21% · α -0.62%
$0.2601
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

SBC Medical Group reported Q1 2026 revenue of $43.1M (3.3% above the $41.7M consensus) but net income attributable to the company fell 47% YoY to $11.3M, with EPS of $0.11 versus $0.21 a year ago. Revenue declined 9% YoY due to a structural franchise fee revision, while EBITDA margin compressed from 52% to 43%. The stock will likely trade down on the sharp earnings decline and margin compression, despite a modest revenue beat.

Key Financial Metrics

EPS
$0.11
Revenue
$43.1M
est $41.7M · +3.3% · -9.0% YoY
Rating
miss
Gross Margin
70.5%

Key Facts

  • Total revenues of $43.1M, down 9% YoY from $47.3M
  • Net income attributable to SBC Medical Group of $11.3M, down 47% YoY from $21.5M
  • EPS of $0.11, down 48% YoY from $0.21
  • EBITDA of $18.4M, down 26% YoY; EBITDA margin 43% vs 52% a year ago
  • Net income margin fell to 26% from 45%
  • Revenue beat the $41.7M consensus by ~3.3%
  • Franchise locations grew to 284 from 251 a year ago; customer count up 10% to 6.76M
  • Operating cash flow improved to $9.2M from $1.9M in the prior-year quarter

Financial Impact

Net income down 47% YoY ($11.3M vs $21.5M); EPS down 48% to $0.11; EBITDA margin down 900 bps to 43%

revenueepsnet incomeebitda marginnet income margin

Risk Factors

  • Continued revenue decline from structural franchise fee revision
  • Further margin compression if operating expenses grow faster than revenue
  • Foreign exchange exposure (Japan-based operations, USD reporting)
  • Low liquidity given $23M market cap and warrant ticker (SBCWW)

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-222720
Document: sbc-20260514.htm0001193125-26-222720
Document: 0001193125-26-222720-index-headers.html0001193125-26-222720
Document: 0001193125-26-222720-index.html0001193125-26-222720
Document: 0001193125-26-222720.txt0001193125-26-222720
8-K Data (Synthetic)0001193125-26-222720
3 reports for SBCWW
Performance horizon
Filters
Rows
Reports for SBCWW — sortable, filterable
TypeNow
May 28, 2026
21w ago
DEFA14A
NEUTRAL ★ 3/10
$0.2496 $0.3349▲ +34.17%▲ +32.44%—
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$0.2496 $0.2601▼ −4.21%▼ −0.62%—
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$0.2496 $0.2399▼ −3.89%▼ −8.90%—
Showing 3 of 3

US Market Status

Market Open — Closes in 3h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026